The Emergence of Multiplexed Technologies as Diagnostic Platforms in Systemic Autoimmune Diseases
The DOI matches its Crossref record.
Abstract
In the last decade, there has been a rapid proliferation of new technologies that are capable of identifying an increasing spectrum of autoantibodies and other biomarkers in autoimmune diseases. These newer diagnostic technologies include line immunoassays, addressable laser bead immunoassays, microarrays in microfluidics platforms and nanobarcode particles. Multiplexed bead assays are a particularly robust platform because they are adaptable to the detection of a variety of disease specific biomarkers, such as autoantibodies, cytokines, adipokines, drugs, oligonucleotides and single nucleotide polymorphisms, Although many laboratories have adopted a variety of these diagnostic platforms to improve turn around times and meet budget constraints, there is an urgent need to ensure that the rapid adoption of new technologies is attended by an appropriate balance of assay sensitivity and specificity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Agmon-Levin, N., Damoiseaux, J., Kallenberg, C., Sack, U., Witte, T., Herold, M., Bossuyt, X., Musset, L., Cervera, R., Plaza-Lopez, A., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203863 · Cited by 615
Self-citationANA screening: an old test with new recommendations
Meroni, P. L., & Schur, P. H. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.127100 · Cited by 533
Autoantibodies in systemic sclerosis
Mehra, S., Walker, J., Patterson, K., & Fritzler, M. J. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.05.011 · Cited by 252
Self-citationStandardization of autoantibody testing: a paradigm for serology in rheumatic diseases
Meroni, P. L., Biggioggero, M., Pierangeli, S. S., Sheldon, J., Zegers, I., & Borghi, M. O. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.180 · Cited by 92
COPPLE, S. S., MARTINS, T. B., MASTERSON, C., JOLY, E., & HILL, H. R. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1398.052 · Cited by 42
Metadata
- Authors
- Fritzler, M., & Fritzler, M.
- Venue
- Current Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2006-09-01
- Volume
- 13
- Issue
- 21
- Pages
- 2503-2512
- ISSN
- 0929-8673 (ISSN-L)
- OpenAlex
- W2061871741
- Cited by
- 54
- References
- 0
- FWCI
- 1.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Emergence of Multiplexed Technologies as Diagnostic Platforms in Systemic Autoimmune Diseases. https://app.cochat.ai/papers/10.2174/092986706778201639
- The paper
- Fritzler, M., & Fritzler, M. (2006). The Emergence of Multiplexed Technologies as Diagnostic Platforms in Systemic Autoimmune Diseases. Current Medicinal Chemistry. https://doi.org/10.2174/092986706778201639
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.